Merck KGaA invests nearly $700 million into venture capital arm M Ventures

Merck KGaA /zigman2/quotes/206962101/delayed MKKGY -0.08% /zigman2/quotes/209909728/delayed XE:MRK -0.19% said Wednesday it will invest an additional 600 million euros (about $680 million) into its corporate venture capital arm M Ventures over the next five years. That's the third increase in financial commitment announced by the Germany-based science and technology company since M Ventures' inception in 2009. "Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems," said Merck KGaA Chief Executive Belén Garijo.

/zigman2/quotes/206962101/delayed

Add to watchlist MKKGY

Merck KGaA ADR

US : U.S.: OTC

$ 32.31

-0.03 -0.08%

Volume: 50,930

Oct. 3, 2023 3:54p

P/E Ratio

21.83

Dividend Yield

1.01%

Market Cap

$70.51 billion

Rev. per Employee

$359,136

/zigman2/quotes/209909728/delayed

Add to watchlist XE:MRK

Merck KGaA

XE : Germany: Xetra

€ 154.20

-0.30 -0.19%

Volume: 164,243

Oct. 3, 2023 6:30p

P/E Ratio

21.78

Dividend Yield

1.43%

Market Cap

€67.17 billion

Rev. per Employee

€343,458